What comes next after the surgical randomized clinical trial?

Markar, S R; Penna, M; Gisbertz, S; Hanna, G B; van Berge Henegouwen, M I; Cuesta, M A

Markar, S R; Penna, M; Gisbertz, S; Hanna, G B; van Berge Henegouwen, M I; Cuesta, M A.

Affiliation

Markar SR; Department Surgery and Cancer, Imperial College London, London, UK.
Penna M; Department Surgery and Cancer, Imperial College London, London, UK.
Gisbertz S; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Centre Amsterdam, Amsterdam, the Netherlands.
Hanna GB; Department Surgery and Cancer, Imperial College London, London, UK.
van Berge Henegouwen MI; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Centre Amsterdam, Amsterdam, the Netherlands.
Cuesta MA; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Centre Amsterdam, Amsterdam, the Netherlands.

Br J Surg ; 108(2): e59, 2021 03 12.

Article de En | MEDLINE | ID: mdl-33711111

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Essais contrôlés randomisés comme sujet / Diffusion des innovations Type d'étude: Clinical_trials / Sysrev_observational_studies Limites: Humans Langue: En Journal: Br J Surg Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google